The location of initial flares and uric acid deposits of gout is frequently in the extremities.
Read MoreWeekly Case Conferences Make for Engaged Learning
Rheumatology fellows at Cleveland Clinic organize a once-a-week case discussion to hone skills clinical reasoning and be posed to a wide variety of diseases and disorders within a complex medical specialty.
Case Study: TNF Inhibitor Plays Role in Unraveling a Challenging Diagnosis
A patient with a long history of inflammation in his right hand seemed an unlikely candidate for the infection that was finally diagnosed.
Optimal Management of High Risk Immunocompromised Patients in the COVID-19 Era
Rheumatologists are called upon to know which patients are more vulnerable to COVID-19, to counsel on risk, and to recommend vaccination and PrEP when appropriate.
Real World Experience with Tixagevimab/Cilgavimab in B-Cell-Depleted Patients
Early results were positive in a study of the preventive treatment of COVID-19 with xagevimab/cilgavimab for patients who were unlikely to respond sufficiently or at all to vaccination.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Multidisciplinary Clinic Brings Specialties Together to Treat Sarcoidosis
Cleveland Clinic’s Multidisciplinary Sarcoidosis Clinic is one of the few such clinics in the country that offers comprehensive care for patients with sarcoidosis.
Reflections on Rheumatology ‘Year in Review’
Dr. Carol Langford, a Cleveland Clinic rheumatologist and an expert in vasculitic diseases, reflects on a year of advances in rheumatology.
Case Study: Mental Health and Socioeconomic Obstacles in Severe, Diffuse Tophaceous Gout
Even with the best therapies available, when patients are experiencing mental health or socioeconomic challenges, medical care can be delayed or hindered. A team approach can help.
Building a Personalized Medicine Approach to PsA Treatment
Cleveland Clinic’s Orthopaedic & Rheumatologic Institute is studying genetic polymorphisms with the aim of improving the understanding of why some individuals do not respond to TNFα blockers. The ultimate goal is to find a new therapeutic approach for those with PsA.
New Onset Eosinophilic Fasciitis after COVID-19 Infection
Soon after her diagnosis of COVID-19, a patient began to experience severe allodynia to light touch over her forearms and shins.
When Edema and Dyspnea Accompany Dyschromic Nails
Dyschromic nails, lymphedema and sinus and lung symptoms point to yellow nail syndrome.